NTRK2 and major depressive disorder: The BDNF-TrkB signaling pathway has been previously demonstrated to modulate brain inflammation and protect against hippocampus injury, suggesting that ADSC-mediated protective effects could be linked to reduced symptoms of depression [98,99].